Trial Profile
A study assessing effect of Dapagliflozin on metabolic control in people with type 2 diabetes using insulin pumps.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association